Synucleinopathies are a group of neurodegenerative disorders that include serious conditions such as Parkinson’s disease and dementia with Lewy bodies. There are currently no cures for these disorders, and treatment is limited to mitigating symptoms. Recently, antibody-based therapies have attracted considerable attention, but alternative approaches are still necessary. Therapy development for synucleinopathies tends to target […]

Finding the RNA aptamer in the haystack that could improve treatment for Parkinson’s
Shubham Ghosh Roy

